Share-based Payment Arrangement, Expense of Zura Bio Ltd from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Zura Bio Ltd quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Zura Bio Ltd Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,379,000, a 72% decline year-over-year.
  • Zura Bio Ltd Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $12,572,000, a 23% decline year-over-year.
  • Zura Bio Ltd annual Share-based Payment Arrangement, Expense for 2024 was $16,798,000, a 74% increase from 2023.
  • Zura Bio Ltd annual Share-based Payment Arrangement, Expense for 2023 was $9,655,000, a 2791% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Zura Bio Ltd Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $12,572,000 $2,379,000 -$6,267,000 -72% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $18,839,000 $3,732,000 +$806,000 +28% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $18,033,000 $3,644,000 +$1,235,000 +51% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $16,798,000 $2,817,000 +$424,000 +18% 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q3 2024 $16,374,000 $8,646,000 +$6,069,000 +236% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $10,305,000 $2,926,000 +$607,000 +26% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $9,698,000 $2,409,000 +$43,000 +1.8% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $9,655,000 $2,393,000 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 $2,577,000 +$2,565,000 +21375% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $2,319,000 +$2,010,000 +650% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $2,366,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 $12,000 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $309,000 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2

Zura Bio Ltd Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $16,798,000 +$7,143,000 +74% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
2023 $9,655,000 +$9,321,000 +2791% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2022 $334,000 18 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.